Sanofi ends two phase 1 cancer assets weeks after axing Sangamo deal
Sanofi ends two phase 1 cancer assets weeks after axing [...]
Sanofi ends 2 phase 1 cancer assets weeks after axing Sangamo deal
Sanofi ends 2 phase 1 cancer assets weeks after axing [...]
Resignation galore: Exicure CEO resigns, CTO departs, 3 board members exit after December woes
Resignation galore: Exicure CEO resigns, CTO departs, 3 board members [...]
UCB races to regulators after $2.5B rare disease bet delivers data for attack on AstraZeneca and argenx
UCB races to regulators after $2.5B rare disease bet delivers [...]
Remote possibilities: United BioSource teams with Seqster to boost decentralized study offering
Remote possibilities: United BioSource teams with Seqster to boost decentralized [...]
Pfizer’s $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies
Pfizer’s $130M Lyme disease vaccine advances to phase 3 after [...]
Unity once again lays off large number of staff, narrows focus to ophthalmology assets
Unity once again lays off large number of staff, narrows [...]
Arrowhead ‘changing horses’ for ENaC pulmonary program as phase 1/2 asset shelved
Arrowhead ‘changing horses’ for ENaC pulmonary program as phase 1/2 [...]
Pfizer accuses former employees of ‘treachery’ in stealing trade secrets to form Regor Therapeutics
Pfizer accuses former employees of ‘treachery’ in stealing trade secrets [...]
Roche lets go of etro, dumping phase 3 Crohn’s prospect 18 months after posting weak colitis data
Roche lets go of etro, dumping phase 3 Crohn’s prospect [...]